Company Filing History:
1 out of 531 
1 out of 870 
Years Active: 2019
Title: The Innovative Contributions of Eva Hong
Introduction
Eva Hong is a notable inventor based in Maisons-Alfort, France. She has made significant contributions to the field of immunology, particularly in the development of vaccines. Her work focuses on combating serogroup X meningococcus, a serious bacterial infection.
Latest Patents
Eva Hong holds a patent for a method of immunizing subjects against serogroup X meningococcus. This innovative vaccine comprises one, two, or all three of the following components: a meningococcal fHbp antigen, a meningococcal NHBA antigen, and/or a meningococcal NadA antigen. Additionally, the vaccine may include meningococcal outer membrane vesicles, enhancing its effectiveness.
Career Highlights
Throughout her career, Eva has worked with prominent organizations in the field of biotechnology. She has been associated with GlaxoSmithKline Biologicals SA and Institut Pasteur, where she has contributed to groundbreaking research and development in vaccine technology.
Collaborations
Eva has collaborated with esteemed colleagues, including Mariagrazia Pizza and Peter Dull. These partnerships have furthered her research and expanded the impact of her innovations in the medical field.
Conclusion
Eva Hong's contributions to vaccine development highlight her role as a leading inventor in immunology. Her innovative approach to combating meningococcal infections demonstrates the importance of research and collaboration in advancing public health.